deltatrials
Completed NA NCT00001995

A Double-Blind Randomized Clinical Trial of a Rifabutin Regimen in the Treatment of Mycobacterium-Avium Complex (MAC) Bacteremia in Patients With AIDS

Sponsor: Pharmacia

Conditions HIV Infections Mycobacterium Avium-Intracellulare Infection
Interventions Rifabutin
Updated 6 times since 2017 Last updated: Jun 23, 2005

This NA trial investigates HIV Infections and Mycobacterium Avium-Intracellulare Infection and is currently completed. Pharmacia leads this study, which shows 6 recorded versions since 2026 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Change History

6 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed NA

  2. Sep 2024 — Sep 2025 [monthly]

    Completed NA

  3. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  4. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  5. Jun 2018 — Jan 2021 [monthly]

    Completed NA

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Completed NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Pharmacia
Data source: NIH AIDS Clinical Trials Information Service

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Annandale, United States, Atlanta, United States, Columbia, United States, East Meadow, United States, Fort Lauderdale, United States, Harbor City, United States, Hollywood, United States, Irvine, United States, Kansas City, United States, Los Angeles, United States and 10 more location s